2012
DOI: 10.1074/jbc.m111.337741
|View full text |Cite
|
Sign up to set email alerts
|

Distinct Properties of Glycine Receptor β+/α− Interface

Abstract: Background: Heteromeric ␣␤ glycine receptor ␤ϩ/␣Ϫ interfaces have never been characterized unambiguously. Results: This interface, compared with the ␣ϩ/␣Ϫ interface, is highly sensitive to agonist and experiences distinct conformational changes upon agonist binding. Conclusion:The ␤ϩ/␣Ϫ interface exhibits distinct properties. Significance: Our investigation directs the ␤ϩ/␣Ϫ interface-specific drug design and provides a general methodology for unambiguously characterizing heteromeric proteins interfaces.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 39 publications
(60 reference statements)
0
2
0
Order By: Relevance
“…This perhaps reiterates that the structure of the agonist-binding site and the binding mode of various agonists are determined not only by ECD amino acid identity but also by length of loops and the orientation of side chains outside of the agonist-binding site (Liu et al, 2005 ; Kehoe et al, 2009 ; Xiu et al, 2009 ). Indeed, Loop A has been proposed as the main determinant of the different agonist recognition by α and β GlyR isoforms (Shan et al, 2012 ), yet their loop A sequences are 100% identical.…”
Section: Chemical and Structural Insights Into Agonist Recognition: Imentioning
confidence: 99%
“…This perhaps reiterates that the structure of the agonist-binding site and the binding mode of various agonists are determined not only by ECD amino acid identity but also by length of loops and the orientation of side chains outside of the agonist-binding site (Liu et al, 2005 ; Kehoe et al, 2009 ; Xiu et al, 2009 ). Indeed, Loop A has been proposed as the main determinant of the different agonist recognition by α and β GlyR isoforms (Shan et al, 2012 ), yet their loop A sequences are 100% identical.…”
Section: Chemical and Structural Insights Into Agonist Recognition: Imentioning
confidence: 99%
“…To this we add the very significant complication that the overwhelming majority of human pLGICs of physiological and pharmacological relevance are heteromeric, with distinct subunit combinations that display unique biophysical and pharmacological profiles. These assemblies are unevenly distributed throughout the CNS and its periphery, and the heterogeneity provides an opportunity for the development of ligands with receptorsubtype specificity (Dutertre et al, 2012;Shan et al, 2012;Webb & Lynch, 2007). In large part, owing to difficulties in the recombinant protein production of heteromeric samples, structural studies are largely restricted to homomeric pLGICs, with a limited capacity to characterize the details of selectivity that can guide the development of selective chemical probes necessary to support fundamental studies or drug discovery.…”
Section: Introductionmentioning
confidence: 99%